Plant ID: NPO5049
Plant Latin Name: Garcinia multiflora
Taxonomy Genus: Garcinia
Taxonomy Family: Clusiaceae
NCBI TaxonomyDB:
1009474
Plant-of-the-World-Online:
n.a.
China
GPR35; | |
PTPN1; PTPRS; | |
TDP1; HSD17B10; APEX1; POLB; | |
GAA; | |
DAPK1; | |
CA2; CA1; CA12; CA9; CA3; CA14; CA5B; CA5A; CA6; CA7; | |
ESR2; | |
MMP1; MMP2; MMP9; | |
TP53; NFKB1; | |
SLC22A12; | |
LMNA; MCL1; THPO; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP2C9; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | P27695 | CHEMBL5619 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Protein Kinase | DAPK1 | Death-associated protein kinase 1 | P53355 | CHEMBL2558 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPRS | Receptor-type tyrosine-protein phosphatase S | Q13332 | CHEMBL2396508 |
SLC superfamily of solute carriers | SLC22A12 | Solute carrier family 22 member 12 | Q96S37 | CHEMBL6120 |
Small molecule receptor (family A GPCR) | GPR35 | G-protein coupled receptor 35 | Q9HC97 | CHEMBL1293267 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | CHEMBL4361 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 5.882E-13 | 1.830E-09 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9, ESR2, MMP1, MMP2, MMP9, PTPN1, TP53 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 9.695E-26 | 2.111E-21 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0006286; base-excision repair, base-free sugar-phosphate removal | 2.659E-06 | 4.825E-03 | APEX1, POLB |
BP | GO:0009987; cellular process | GO:0033554; cellular response to stress | 2.952E-06 | 4.944E-03 | APEX1, CA2, CA9, DAPK1, LMNA, MCL1, MMP9, NFKB1, POLB, PTPN1, TDP1, TP53 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 7.968E-06 | 9.505E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 7.773E-20 | 5.642E-16 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.491E-18 | 1.085E-14 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 3.972E-05 | 2.883E-02 | CA1, CA2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 4.425E-25 | 4.558E-23 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA7, CA6, CA9, CA14 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 5.437E-09 | 2.800E-07 | MMP1, DAPK1, MMP2, MMP9, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 3.448E-05 | 1.184E-03 | MMP1, DAPK1, MMP2, TP53, MMP9, NFKB1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 7.102E-05 | 1.829E-03 | LMNA, TP53, NFKB1, MCL1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 5.258E-04 | 1.083E-02 | MMP2, MMP9, ESR2 |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 1.235E-03 | 1.868E-02 | TP53, MMP9, NFKB1, MCL1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 1.619E-03 | 2.084E-02 | TP53, MMP9, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 4.114E-03 | 3.960E-02 | MMP2, TP53, MMP9 |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 2.935E-03 | 3.359E-02 | TP53, MMP9, NFKB1 |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03410 | Base excision repair | 1.270E-03 | 1.868E-02 | POLB, APEX1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP2; |
C00-D49: Neoplasms | Ovarian cancer | C56 | MMP2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Acne vulgaris | L70.0 | MMP2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MMP9; MMP2; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | MMP9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
C00-D49: Neoplasms | Renal cell carcinoma | NA | MMP2; |
K00-K95: Diseases of the digestive system | Ulcerative colitis | K51 | MMP9; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; MMP9; MMP2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | MMP1; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2; |
C00-D49: Neoplasms | Lung cancer | C33-C34 | MMP2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | MMP1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic nephropathy | E11.21 | MMP1; |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2; |
I00-I99: Diseases of the circulatory system | Stroke | I61-I63, I80-I82 | MMP9; |